Literature DB >> 8543969

Spinal 111Indium-DTPA CSF flow studies in leptomeningeal metastasis.

M C Chamberlain1.   

Abstract

Sixteen consecutive patients (8 men; 8 women; age range 6-63 years, median 40 years) with leptomeningeal metastasis were found by radionuclide ventriculography to have cerebrospinal fluid (CSF) flow interruption at the following sites: cisterna magna/basal cisterns (6); cervical (5) and thoracic (3) spinal subarachnoid space. Two additional patients had no evidence of interruption of CSF flow. All patients underwent intralumbar injection of 111Indium-DTPA and imaging of spinal ascent of radionuclide, corroborating sites of CSF flow disruption seen by radionuclide ventriculography. Median (range) time to appearance in lumbar, thoracic and cervical spinal subarachnoid compartments were 1 (1), 22.5 (20-25) and 32.5 (30-35) minutes respectively. Appearance of radionuclide in the cisterna magna/basal cisterns, sylvian cisterns, ventricular system and high cerebral convexity was 37.5 (35-40), 65 (60-70), 1440 (1440) and 1440 (1440) minutes respectively. Only 1 of 8 patients with interruption of CSF flow within the spinal subarachnoid space shown by intralumbar radionuclide flow study, was seen by either CT myelography or contrast enhanced spine MR to have CSF flow block. No patient with base of brain block (0/6) shown by radionuclide CSF flow studies demonstrated CSF flow disruption by either cranial contrast enhanced CT or MR. In conclusion, spinal 111In-DTPA CSF flow studies confirmed sites of CSF flow block shown by radionuclide ventriculography and demonstrate the feasibility of assessing CSF compartmentalization by intralumbar radionuclide administration. Furthermore, radionuclide CSF flow studies when compared to conventional neuroradiographic imaging are more sensitive in demonstrating interruption of CSF flow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543969     DOI: 10.1007/bf01057757

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  10 in total

Review 1.  Neoplastic meningitis.

Authors:  S A Grossman; T J Moynihan
Journal:  Neurol Clin       Date:  1991-11       Impact factor: 3.806

2.  Spinal descent of cerebrospinal fluid in man.

Authors:  G D Chiro; M K Hammock; W A Bleyer
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

3.  Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain.

Authors:  M C Chamberlain; A D Sandy; G A Press
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

4.  The radionuclide ventriculogram.

Authors:  S M Larson; G S Johnston; A K Ommaya; A E Jones; G Di Chiro
Journal:  JAMA       Date:  1973-05-07       Impact factor: 56.272

5.  Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.

Authors:  R G Blasberg; C S Patlak; W R Shapiro
Journal:  Cancer Treat Rep       Date:  1977-07

6.  Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections.

Authors:  W R Shapiro; D F Young; B M Mehta
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

7.  Leptomeningeal metastases: 111indium-DTPA CSF flow studies.

Authors:  M C Chamberlain; J Corey-Bloom
Journal:  Neurology       Date:  1991-11       Impact factor: 9.910

8.  Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography.

Authors:  S A Grossman; D L Trump; D C Chen; G Thompson; E E Camargo
Journal:  Am J Med       Date:  1982-11       Impact factor: 4.965

9.  Normal cerebrospinal fluid dynamics. A study with intraventricular injection of 111In-DTPA in leukemia and lymphoma without meningeal involvement.

Authors:  H Haaxma-Reiche; A Piers; H Beekhuis
Journal:  Arch Neurol       Date:  1989-09

10.  Comparative spine imaging in leptomeningeal metastases.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

  10 in total
  7 in total

1.  Phase-contrast cerebrospinal fluid flow magnetic resonance imaging in qualitative evaluation of patency of CSF flow pathways prior to infusion of chemotherapeutic and other agents into the fourth ventricle.

Authors:  Rajan P Patel; Clark W Sitton; Leena M Ketonen; Ping Hou; Jason M Johnson; Seferino Romo; Stephen Fletcher; Manish N Shah; Marcia Kerr; Wafik Zaky; Michael E Rytting; Soumen Khatua; David I Sandberg
Journal:  Childs Nerv Syst       Date:  2017-11-23       Impact factor: 1.475

2.  Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome.

Authors:  Jai Grewal; Marlon Saria; Harpreet K Grewal; Santosh Kesari
Journal:  Clin Investig (Lond)       Date:  2011-10

Review 3.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 4.  Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.

Authors:  Gudrun Fleischhack; Ulrich Jaehde; Udo Bode
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 5.  Leptomeningeal metastases: a review of evaluation and treatment.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1998-05       Impact factor: 4.130

6.  Comprehensive neuraxis imaging in leptomeningeal metastasis: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-03

7.  Radioisotope CSF flow studies in leptomeningeal metastases.

Authors:  M C Chamberlain
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.